Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 May;101(5):323-324.
doi: 10.1016/j.diii.2020.03.010. Epub 2020 Mar 31.

Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab

M Cellina  1 , M Orsi  2 , F Bombaci  2 , M Sala  3 , P Marino  3 , G Oliva  2
Affiliations
Comment

Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab

M Cellina et al. Diagn Interv Imaging. 2020 May.
No abstract available

Keywords: COVID-19; Computed tomography; Coronavirus; Pneumonia; Severe acute respiratory syndrome coronavirus 2; Viral.

PubMed Disclaimer

Figures

Figure 1
Figure 1
64-year-old man who received tocilizumab as a treatment of COVID-19 pneumonia. A. Unenhanced CT image of the lungs in the transverse plane obtained at day 7 shows diffuse air space opacities, mainly consolidations, with poorly represented ground glass opacities. The distribution is bilateral, with predominant posterior location. Linear opacities are bilateral, even if more evident on the left side. Diffuse thickening of the bronchial walls is present, as well as mild bilateral pleural effusion. B. On mediastinal window, unenhanced CT image shows mediastinal lymphadenopathy (arrow). C. Unenhanced CT image of the lungs in the transverse plane obtained at day 14 shows marked improvement of CT findings, with bilateral reduction of consolidations. Some ground glass opacities are still visible, with predominant peripheral and posterior location. Peripheral linear striped opacities are visible. D. On mediastinal window, unenhanced CT image shows mild decrease in size of mediastinal lymphadenopathy.
See this image and copyright information in PMC

Comment on

  • Effective treatment of severe COVID-19 patients with tocilizumab.
    Xu X, Han M, Li T, Sun W, Wang D, Fu B, Zhou Y, Zheng X, Yang Y, Li X, Zhang X, Pan A, Wei H. Xu X, et al. Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. doi: 10.1073/pnas.2005615117. Epub 2020 Apr 29. Proc Natl Acad Sci U S A. 2020. PMID: 32350134 Free PMC article.

References

    1. Fang Y., Zhang H., Xie J., Lin M., Ying L., Pang P. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. 2020 doi: 10.1148/radiol.2020200432. - DOI - PMC - PubMed
    1. Xu X, Han M, Li T, Sun W, Wang D, Fu B, et al. Effective treatment of severe COVID-19 patients with tocilizumab. ChinaXiv: 202003.00026v1. - PMC - PubMed
    1. Pan F., Ye T., Sun P., Gui S., Liang B., Li L. Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology. 2020 doi: 10.1148/radiol.2020200370. - DOI - PMC - PubMed

Substances